Arizona Ash Allergy Shots: The Southwest's January Oleaceae Trigger
Arizona ash allergy shots (SCIT) target the Southwest's 'January surprise' — Fraxinus velutina peaks January–March in Phoenix, Sacramento, and the SF Bay Area, overlapping mountain cedar's tail end and creating a dual Oleaceae-plus-Cupressaceae pollen window. Fra e 1 shares 88% identity with olive's Ole e 1, so SCIT cross-protects the full Oleaceae family.
Arizona Ash Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to arizona ash — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of arizona ash allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of arizona ash immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of arizona ash extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for arizona ash allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing arizona ash extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription arizona ash immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat arizona ash allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Arizona Ash?
The biology, taxonomy, and clinical fingerprint of Arizona Ash — the foundation of how SCIT targets it.
Fraxinus velutina (Arizona ash) releasing pollen in Phoenix January–March. Its early-season peak overlaps with mountain cedar decline and Arizona cypress, creating a multi-allergen winter window.
- Scientific name
- Fraxinus velutina
- Family
- OleaceaeOlive family
- Type
- Winter-spring tree pollen
- Native to
- Southwestern United States and northern Mexico; widely planted as ornamental in Phoenix, Tucson, Sacramento, and the SF Bay Area
- Allergen proteins
- Fra e 1 (major) — Ole e 1-like family, ~20 kDa; 88% sequence identity with Ole e 1 (olive), 91% with Lig v 1 (privet) — Niederberger 2002Note: WHO/IUIS lists Fra e 1 for European ash (Fraxinus excelsior); F. velutina expresses homologous proteins but is not separately characterized in WHO/IUIS as of 2025 (allergen.org)
- Particle size
- ~22 μm, tricolporate
- Avoidance difficulty
- Very difficult
How Arizona Ash Allergy Presents
Symptoms by body system — useful for distinguishing Arizona Ash sensitivity from overlapping allergies and infections.
Respiratory
- Nasal congestion and profuse rhinorrhea beginning in January in Phoenix and the Bay Area
- Sneezing episodes during outdoor exposure when ash catkins are releasing
- Asthma exacerbations in sensitized patients during the January–February peak
- Chronic cough and postnasal drip through the March season close
- Sinusitis from prolonged mucosal inflammation across the winter-spring transition
Ocular
- Bilateral eye itching and watering during January–March outdoor exposure
- Periorbital swelling on high-count days in Phoenix and Sacramento
- Photophobia and persistent redness during peak pollen release
Dermal
- Contact urticaria from handling ash foliage during yard work
- Generalized itching on high-pollen days in highly sensitized individuals
- Eczema flares in atopic patients coinciding with January–March tree-pollen peak
Systemic
- Fatigue from sustained winter allergy burden in Phoenix and Bay Area
- Sleep disruption from nocturnal nasal blockage during January peak
- Headache from sinus pressure on high-count days
- Reduced productivity across the winter allergy season
Arizona ash and Arizona cypress create a twin January peak in Phoenix — patients often present with overlapping Oleaceae and Cupressaceae exposures in the same week. Component testing that distinguishes ash Fra e 1 from cypress Cup a 1 matters because the cross-reactivity patterns and treatment strategies for each family are completely different.
When & Where Arizona Ash Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: late January through February in Phoenix and Sacramento; Shamel ash (Bay Area) peaks late January· ~8–10 weeks January–March; season has shifted earlier per Anderegg et al. PNAS 2021
US Exposure Map
2 high-intensity statesWhat Arizona Ash Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Arizona ash's Fra e 1 allergen is functionally identical to white ash's Fra e 1 and shares 88% sequence identity with olive's Ole e 1 — placing ash-sensitized patients squarely in the Oleaceae cross-reactivity network that includes privet, lilac, and Russian olive. In Phoenix and the Bay Area, patients may encounter both Oleaceae (ash, Jan–March) and Cupressaceae (Arizona cypress, Jan–Feb) simultaneously, but these are distinct protein families with separate cross-reactivity maps.
Same Fraxinus genus; cross-protection within genus essentially complete via shared Fra e 1
Fra e 1 shares 91% identity with Lig v 1 — strongest Oleaceae intra-family cross-reactivity (Niederberger 2002)
Is SCIT Right for Your Arizona Ash Allergy?
Answer five questions to see whether Arizona ash SCIT fits your winter allergy profile.
How severe are your January–March allergy symptoms in the Southwest or Bay Area?
The Arizona Ash SCIT Protocol
Arizona ash SCIT uses a non-standardized extract anchored to Fra e 1. Build-up typically begins in summer (July–August) to reach maintenance before January ash season in Phoenix and Sacramento.
Incremental dose escalation from the most dilute vial. Because ash and olive share 88% Ole e 1-like identity, your allergist may combine ash with olive extract in a single vial to address the full Oleaceae exposure spectrum. With at-home SCIT through Curex, the first injection and every dose increase are supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand and a 30-minute self-observation after each injection.
Monthly maintenance injections sustain Fra e 1-specific tolerance, with immunologic markers shifting over 12–18 months. The Oleaceae cross-protection documented by Niederberger 2002 means maintenance ash injections also cross-protect against olive (April–June in California) and privet (May–July).
After completing 3–5 years of maintenance, your allergist assesses durable tolerance. Many patients sustain reduced winter allergy symptoms for years post-SCIT, though individual durability varies.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Arizona Ash SCIT
Arizona ash SCIT is supported by Oleaceae cross-reactivity data rather than a species-specific US RCT. No US RCT specific to Arizona ash or Fraxinus velutina exists as of 2025.
- Fra e 1 / Ole e 1 sequence identity (cross-protection basis)88%Niederberger V, et al. Clin Exp Allergy 2002;32:933–941 — olive AIT cross-protects ash and vice versa via Ole e 1-like family
- Fra e 1 / Lig v 1 identity (family cross-protection)91%Niederberger V, et al. Clin Exp Allergy 2002;32:933–941 — 91% identity establishes full Oleaceae cross-protection
- EU standardized ash extract diagnostic quality65%Hrabina M, et al. Int Arch Allergy Immunol 2007;142:13–21 — EU ash extract standardization and skin-test reactivity validation
No randomized controlled trial specific to Arizona ash SCIT has been published as of 2025. Clinical use is anchored to the Oleaceae cross-protection mechanism (Niederberger 2002), the EU ash extract development (Hrabina 2007), and the AVANZ olive SCIT trial (Pareja 2015) — all of which support ash-anchored SCIT as scientifically rational for Oleaceae-sensitized Southwest patients. The honest framing: evidence quality is moderate, but the molecular rationale for treatment is strong.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Arizona Ash SCIT Side Effects
Arizona ash SCIT carries the standard inhalant immunotherapy side-effect profile. Local injection-site reactions are expected during build-up; serious systemic reactions are rare under proper protocols.
Local reactions
4 documentedSystemic reactions
4 documentedArizona ash SCIT has traditionally been administered in an allergy office with epinephrine and resuscitation equipment available; for eligible maintenance patients, Curex makes safe at-home self-administration possible with a personalized serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first dose and every dose change supervised live over Zoom by a board-certified allergist. A 30-minute self-observation follows every dose and captures the vast majority of systemic reactions (Greenhawt et al., Ann Allergy Asthma Immunol 2023).
SCIT vs Alternatives for Arizona Ash
Southwest patients with Arizona ash allergy have four options: SCIT (best evidence for Oleaceae family cross-protection), at-home SLIT drops, avoidance, or daily antihistamines and nasal steroids.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Best for moderate-severe ash AR; Oleaceae family cross-protection via Niederberger 2002 | Emerging evidence; Ole e 1-like drops show immunologic activity | Nearly impossible in Phoenix and Bay Area with dense ash plantings | Good for mild-moderate ash AR; may be insufficient at peak counts |
| 5-yr cost | $3,500–$15,000 over 5 years | $39–$150/month depending on provider | Low direct cost; high lifestyle burden | $300–$1,200/year for prescriptions |
| Duration | 3–5 years weekly then monthly | 3–5 years daily drops | Permanent lifestyle restriction | Lifelong daily use during season |
| Convenience | Weekly at-home self-injection for ~6 months with Curex; first dose and dose changes supervised live over Zoom | At-home; no clinic visits needed | HEPA filtration indoors helps; outdoor avoidance in January–March impractical | Convenient daily pills and nasal sprays |
| Safety | Excellent; rare systemic reactions, with a sterile-compounded serum, a prescribed epinephrine auto-injector on hand, and live Zoom supervision of every dose change | Lower systemic reaction risk than SCIT | No treatment risk; no disease modification | Well-established safety profile |
| Lasting effect | Years of lasting benefit after completing course | Duration of benefit still being studied | No lasting benefit; symptoms return every winter | No lasting benefit; symptoms return when medications stop |
SCITBest
SLIT
Avoidance
Medications
For Southwest patients with moderate-to-severe Arizona ash allergy who want Oleaceae-wide protection covering ash, olive, privet, and Russian olive, SCIT is the best-evidenced option — now available from Curex as a weekly at-home allergy shot at $129/month, with a serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first dose and every dose change supervised live over Zoom by a board-certified allergist. Sublingual drops remain a general allergy modality some providers offer for patients who prefer a needle-free option.
What Arizona Ash SCIT Actually Costs
Most major US insurers cover Arizona ash SCIT under standard allergy benefits when prescribed by a board-certified allergist. In Phoenix and the Bay Area, ash is a well-recognized regional aeroallergen and coverage is generally straightforward. Out-of-pocket cost depends on your plan's deductible and co-insurance. Curex at-home IgE testing identifies specific arizona ash sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your arizona ash allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Arizona Ash SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Arizona ash (Fraxinus velutina) and white ash (Fraxinus americana) are closely related species sharing the same Fra e 1 major allergen and essentially identical cross-reactivity profiles. The critical difference is geography and timing: Arizona ash peaks January–March in the Southwest (Phoenix, Tucson, Sacramento, SF Bay Area), while white ash peaks March–April in the eastern US. Both species cross-protect each other and the full Oleaceae family via shared Fra e 1 / Ole e 1-like protein chemistry. A patient moving from the Mid-Atlantic to Phoenix will experience the same allergic proteins earlier in the year.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.